Terence Flynn analyst MORGAN STANLEY

Currently out of the existing stock ratings of Terence Flynn, 103 are a HOLD (40.39%), 29 are a SELL (11.37%), 123 are a BUY (48.24%).

Terence Flynn

Work Performance Price Targets & Ratings Chart

Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 69.3% that have a potential upside of 23.61% achieved within 220 days.

Terence Flynn’s has documented 567 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 01-Nov-2024.

Wall Street Analyst Terence Flynn

Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.

Average potential price target upside

ALKS Alkermes Plc ALNY Alnylam Pharmaceuticals ALXN Alexion Pharmaceuticals AMGN Amgen ARVN Arvinas BIIB Biogen BPMC Blueprint Medicines Corp CELG Celgene FGEN FibroGen GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany OGN Organon PFE Pfizer REGN Regeneron Pharmaceuticals RVNC Revance The TBIO Telesis Bio . AGIO Agios Pharm VRTX Vertex Pharmaceuticals ABBV AbbVie BMY Bristol-Myers Squibb Company CLVS Clovis Oncology JNJ Johnson & Johnson RPRX Royalty Pharma Plc UTHR United Therapeutics XLRN Acceleron Pharma NTLA Intellia Therapeutics AGN Allergan plc CCCC C4 Therapeutics  CRSP Crispr Therapeutics AG CTMX CytomX Therapeutics ITMN InterMune MGTA Magenta Therapeutics RCUS Arcus Biosciences NRIX Nurix Therapeutics 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$26

$-0.47 (-1.78%)

$32

14 days ago
(25-Oct-2024)

4/7 (57.14%)

$-0.09 (-0.34%)

26

Buy

$37

$10.53 (39.78%)

$39

14 days ago
(25-Oct-2024)

3/8 (37.5%)

$10.91 (41.82%)

101

Buy

$30

$3.53 (13.34%)

$37

14 days ago
(25-Oct-2024)

7/16 (43.75%)

$3.91 (14.99%)

389

Hold

$37

$10.53 (39.78%)

$37

14 days ago
(25-Oct-2024)

13/21 (61.9%)

$10.91 (41.82%)

244

Sell

$25

$-1.47 (-5.55%)

$31

8 months 19 days ago
(20-Feb-2024)

2/2 (100%)

$-5.39 (-17.74%)

86

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Terence Flynn is most bullish on?

Potential upside of $287.07 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Terence Flynn is most reserved on?

Potential downside of -$53.02 has been obtained for UTHR (UNITED THERAPEUTICS)

What Year was the first public recommendation made by Terence Flynn?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?